A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill Patients
NCT ID: NCT02213978
Last Updated: 2022-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1114 participants
OBSERVATIONAL
2014-08-31
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Long-term Surveillance of Patients With Venous Thromboembolism: a Nationwide Prospective Cohort Study
NCT06073366
The Efficacy and Safety of Dabigatran Etexilate for the Treatment of Cerebral Venous Thrombosis
NCT03217448
Venous Thromboembolism Prophylaxis in Medical and Surgical ICUs in a Single University Hospital
NCT01851239
Value of D-dimer Combined With Other Thrombus Molecular Markers in Risk Assessment of VTE in Hospitalized Patients
NCT05515549
Risk Factors for Venous Thromboembolism in the Community
NCT00011180
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beijing Chao Yang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xiao Tang
doctor of the department of respiratory and critical care medicine of Beijing Chao Yang Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xiao Tang, MD
Role: PRINCIPAL_INVESTIGATOR
Beijing Chao-Yang Hospital,China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of respiratory and critical care medicine,Beijing Chao-yang Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lyu WR, Tang X, Jin Y, Wang R, Li XY, Li Y, Zhang CY, Zhao W, Tong ZH, Sun B. Hemorrhages and risk factors in patients undergoing thromboprophylaxis in a respiratory critical care unit: a secondary data analysis of a cohort study. J Intensive Care. 2024 Oct 29;12(1):43. doi: 10.1186/s40560-024-00756-w.
Tang X, Lyu WR, Jin Y, Wang R, Li XY, Li Y, Zhang CY, Zhao W, Tong ZH, Sun B. Modern thromboprophylaxis protocol based on guidelines applied in a respiratory intensive care unit: a single-center prospective cohort study. Thromb J. 2022 Dec 12;20(1):76. doi: 10.1186/s12959-022-00439-2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ICU-VTE-2014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.